跳至主要内容
临床试验/NCT03650309
NCT03650309已完成不适用

Deep Brain Stimulation for the Treatment of Refractory Morbid Obesity

University Health Network, Toronto2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2018年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6
试验地点
2
主要终点
Incidence of Treatment-Emergent Adverse Events

研究概览

简要总结

This is an open-label, phase I pilot trial designed to evaluate the safety and feasibility of deep brain stimulation (DBS) for the treatment of refractory morbid obesity. Patients with diagnoses of morbid obesity will be recruited and enrolled. All patients will receive DBS targeting two brains areas involved in the pathophysiology of obesity and will be followed post-operatively for 12 months.

详细描述

This study will establish 1)the safety of deep brain stimulation (DBS) in a patient population with treatment refractory morbid obesity. DBS has been used safely and effectively in thousands of patients for numerous disorders. Recent evidence (outlined above) has shown that DBS can also be used to manage refractory psychiatric conditions, such as depression and obsessive-compulsive disorder, as well as in eating disorders such as anorexia nervosa. Such studies indicate that a targeted therapy informed by the neuroanatomic and circuitry literature can be effective in altering pathological mood and behaviour. 2) evaluate the effectiveness of the procedure, which will be evaluated by the actual weight loss and resolution of the core symptoms of morbid obesity, including BMI, as well of, depression, self-esteem, and binge eating scores surrounding with loss or weight gain.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Female or Male patients between age 20-60
  • Diagnosis of Morbid Obesity (defined as a BMI>40kg/m2 or BMI>35 with 1 obesity related comorbidity) OR a diagnosis of Binge Eating Disorder not responsive to recommended treatments (as defined by the DSM-5)
  • Failure or non eligibility of bariatric surgery with <50% of excess weight loss, with or without BMI>35 kg/m2, at 18 months or more after the operation; OR diagnosis of binge eating disorder for over 18 months
  • Diagnosis of food dependence via Yale Food Addiction Scale (YFAS) criteria
  • Normal neurological exam
  • Normal head CT scan and cerebral MRI
  • Patient informed and able to give written consent
  • Able to comply with all testing, follow-ups and study appointments and protocols

排除标准

  • Active neurologic disease such as epilepsy
  • Alcohol or substance dependence or abuse in the last 6 months, excluding caffeine and nicotine
  • Any contraindication to magnetic resonance imaging (MRI) or positron emission tomography (PET) scanning
  • Likely to relocate or move during the study's one year duration
  • Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions as a result of morbid obesity, that will result in significant risk from a surgical procedure.
  • Presence of epilepsy, stroke or degenerative disorder of the nervous system

结局指标

主要结局

Incidence of Treatment-Emergent Adverse Events

时间窗: 12 months

Patients will be closely monitored for adverse events following DBS surgery with regular check-ups.

次要结局

  • Weight(12 months)
  • 'Quality of Life Scale' Questionnaire(12 months)
  • 'Generalized Anxiety Disorder 7-item (GAD-7)' Questionnaire(12 months)
  • 'Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS)' Questionnaire(12 months)
  • 'Emotional Eating Scale (EES)' Questionnaire(12 months)
  • 'Eating Disorder Examination Questionnaire (EDE-Q)'(12 months)
  • 'Binge Eating Scale (BES)' Questionnaire(12 months)
  • 'Yale Food Addiction Scale (YFAS)' Questionnaire(12 months)
  • 'Difficulties in Emotion Regulation Scale (DERS)' Questionnaire(12 months)
  • 'Patient Health Questionnaire (PHQ-9)' Questionnaire(12 months)
  • 'Power of Food (POF)' Questionnaire(12 months)
  • 'Behavioral Inhibition System/Behavioral Activation System Scales (BIS/BAS Scales)' Questionnaire(12 months)
  • 'Yale-Brown Obsessive Compulsive Scale (Y-BOCS)' Questionnaire(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andres M. Lozano

Neurosurgeon, Professor of Surgery

University Health Network, Toronto

研究点 (2)

Loading locations...

相似试验

Deep Brain Stimulation for Morbid Obesity | 临床试验